Cargando…
Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model
Ongoing Ebola virus disease outbreaks in the Democratic Republic of the Congo follow the largest recorded outbreak in Western Africa (2013–2016). To combat outbreaks, testing of medical countermeasures (therapeutics or vaccines) requires a well-defined, reproducible, animal model. Here we present Eb...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411891/ https://www.ncbi.nlm.nih.gov/pubmed/32674252 http://dx.doi.org/10.3390/v12070753 |
_version_ | 1783568483632545792 |
---|---|
author | Bennett, Richard S. Logue, James Liu, David X. Reeder, Rebecca J. Janosko, Krisztina B. Perry, Donna L. Cooper, Timothy K. Byrum, Russell Ragland, Danny St. Claire, Marisa Adams, Ricky Burdette, Tracey L. Brady, Tyler M. Hadley, Kyra Waters, M. Colin Shim, Rebecca Dowling, William Qin, Jing Crozier, Ian Jahrling, Peter B. Hensley, Lisa E. |
author_facet | Bennett, Richard S. Logue, James Liu, David X. Reeder, Rebecca J. Janosko, Krisztina B. Perry, Donna L. Cooper, Timothy K. Byrum, Russell Ragland, Danny St. Claire, Marisa Adams, Ricky Burdette, Tracey L. Brady, Tyler M. Hadley, Kyra Waters, M. Colin Shim, Rebecca Dowling, William Qin, Jing Crozier, Ian Jahrling, Peter B. Hensley, Lisa E. |
author_sort | Bennett, Richard S. |
collection | PubMed |
description | Ongoing Ebola virus disease outbreaks in the Democratic Republic of the Congo follow the largest recorded outbreak in Western Africa (2013–2016). To combat outbreaks, testing of medical countermeasures (therapeutics or vaccines) requires a well-defined, reproducible, animal model. Here we present Ebola virus disease kinetics in 24 Chinese-origin rhesus monkeys exposed intramuscularly to a highly characterized, commercially available Kikwit Ebola virus Filovirus Animal Non-Clinical Group (FANG) stock. Until reaching predetermined clinical disease endpoint criteria, six animals underwent anesthesia for repeated clinical sampling and were compared to six that did not. Groups of three animals were euthanized and necropsied on days 3, 4, 5, and 6 post-exposure, respectively. In addition, three uninfected animals served as controls. Here, we present detailed characterization of clinical and laboratory disease kinetics and complete blood counts, serum chemistries, Ebola virus titers, and disease kinetics for future medical countermeasure (MCM) study design and control data. We measured no statistical difference in hematology, chemistry values, or time to clinical endpoint in animals that were anesthetized for clinical sampling during the acute disease compared to those that were not. |
format | Online Article Text |
id | pubmed-7411891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74118912020-08-25 Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model Bennett, Richard S. Logue, James Liu, David X. Reeder, Rebecca J. Janosko, Krisztina B. Perry, Donna L. Cooper, Timothy K. Byrum, Russell Ragland, Danny St. Claire, Marisa Adams, Ricky Burdette, Tracey L. Brady, Tyler M. Hadley, Kyra Waters, M. Colin Shim, Rebecca Dowling, William Qin, Jing Crozier, Ian Jahrling, Peter B. Hensley, Lisa E. Viruses Article Ongoing Ebola virus disease outbreaks in the Democratic Republic of the Congo follow the largest recorded outbreak in Western Africa (2013–2016). To combat outbreaks, testing of medical countermeasures (therapeutics or vaccines) requires a well-defined, reproducible, animal model. Here we present Ebola virus disease kinetics in 24 Chinese-origin rhesus monkeys exposed intramuscularly to a highly characterized, commercially available Kikwit Ebola virus Filovirus Animal Non-Clinical Group (FANG) stock. Until reaching predetermined clinical disease endpoint criteria, six animals underwent anesthesia for repeated clinical sampling and were compared to six that did not. Groups of three animals were euthanized and necropsied on days 3, 4, 5, and 6 post-exposure, respectively. In addition, three uninfected animals served as controls. Here, we present detailed characterization of clinical and laboratory disease kinetics and complete blood counts, serum chemistries, Ebola virus titers, and disease kinetics for future medical countermeasure (MCM) study design and control data. We measured no statistical difference in hematology, chemistry values, or time to clinical endpoint in animals that were anesthetized for clinical sampling during the acute disease compared to those that were not. MDPI 2020-07-14 /pmc/articles/PMC7411891/ /pubmed/32674252 http://dx.doi.org/10.3390/v12070753 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bennett, Richard S. Logue, James Liu, David X. Reeder, Rebecca J. Janosko, Krisztina B. Perry, Donna L. Cooper, Timothy K. Byrum, Russell Ragland, Danny St. Claire, Marisa Adams, Ricky Burdette, Tracey L. Brady, Tyler M. Hadley, Kyra Waters, M. Colin Shim, Rebecca Dowling, William Qin, Jing Crozier, Ian Jahrling, Peter B. Hensley, Lisa E. Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model |
title | Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model |
title_full | Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model |
title_fullStr | Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model |
title_full_unstemmed | Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model |
title_short | Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model |
title_sort | kikwit ebola virus disease progression in the rhesus monkey animal model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411891/ https://www.ncbi.nlm.nih.gov/pubmed/32674252 http://dx.doi.org/10.3390/v12070753 |
work_keys_str_mv | AT bennettrichards kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT loguejames kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT liudavidx kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT reederrebeccaj kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT janoskokrisztinab kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT perrydonnal kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT coopertimothyk kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT byrumrussell kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT raglanddanny kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT stclairemarisa kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT adamsricky kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT burdettetraceyl kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT bradytylerm kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT hadleykyra kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT watersmcolin kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT shimrebecca kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT dowlingwilliam kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT qinjing kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT crozierian kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT jahrlingpeterb kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel AT hensleylisae kikwitebolavirusdiseaseprogressionintherhesusmonkeyanimalmodel |